The reduced access conditions of minimally invasive surgery and therapy (MIST) impair or completely eliminate the feel of tool—tissue interaction forces. Many researchers have been working actively on the development of force sensors and sensing techniques to address this problem. The goal of this survey article is to summarize the state of the art in force sensing techniques for medical interventions in order to identify existing limitations and future directions. A literature search was performed from January to July 2009 using a combination of keywords relevant to the area, including force, sensor, sensing, haptics, and minimally invasive surgery. The literature search resulted in 126 articles with valuable content. This article presents a summary of the force sensing technologies, design specifications for force sensors in clinical applications, force sensors and sensing instruments that have been developed for MIST, and the experiments performed to determine the need for force information. Open areas of research include force sensor design, development of alternative methods of sensing, assessment of the impact of force information on performance, determination of the benefits of haptic information, and evaluation of the human factors involved in the processing and use of force information.
The 10 mm incisions used in minimally invasive cancer surgery prevent the direct palpation of internal organs, making intraoperative tumor localization difficult. A tactile sensing instrument (TSI), which uses a commercially available sensor to measure distributed pressure profiles along the contacting surface, has been developed to facilitate remote tissue palpation. The objective of this research is to assess the feasibility of using the TSI under robotic control to reliably locate underlying tumors while reducing collateral tissue trauma. The performance of humans and a robot using the TSI to locate tumor phantoms embedded into ex vivo bovine livers is compared. An augmented hybrid impedance control scheme has been implemented on a Mitsubishi PA10-7C to perform the force/position control used in the trials. The results show that using the TSI under robotic control realizes an average 35% decrease in the maximum forces applied and a 50% increase in tumor detection accuracy when compared to manual manipulation of the same instrument. This demonstrates that the detection of tumors using tactile sensing is highly dependent on how consistently the forces on the tactile sensing area are applied, and that robotic assistance can be of great benefit when trying to localize tumors in minimally invasive surgery.
Results of a study on the restricted motion of manipulators in robotics-assisted minimally invasive surgery are presented in this paper. The governing equations of trocar kinematics are derived and the constrained manipulation is generically formulated in terms of the trocar geometry as well as the kinematics of the manipulator. The results are validated through a numerical simulation with a Mitsubishi PA10-7C arm. Following this analysis, by utilizing the constrained manipulation formulation, a modified measure of manipulability, specifically applicable to surgical tasks, is proposed. The measure is proven to be frame-invariant and dimensionally homogeneous for manipulators with similar joints (revolute or prismatic). Furthermore, the measure is shown to be capable of quantifying the impact of trocar constraints on surgical task performance when the remote center of motion is maintained through active compliant motion control.
A sensing range of 0-2 N, with 0.01 N resolution, should allow a kinaesthetic palpation probe to resolve local tissue stiffness changes that suggest an underlying tumour.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.